Richmond
Stories
-
Lilly breaks ground on $5 billion Richmond facility to produce API and finished medicines
Eli Lilly and Company announced on Oct. 22, 2026 that it broke ground on a $5 billion manufacturing facility just west of Richmond, Virginia, the company's first fully integrated site to produce both active pharmaceutical ingredients and finished antibody-drug conjugates. The new plant is expected to create 650 high-wage jobs and about 1,800 construction jobs during construction.